What Are the Common Challenges in Phase II Trials?
One of the main challenges in Phase II trials is the balance between efficacy and safety. While the primary focus is on determining whether the treatment works, researchers must also continue to monitor and manage any adverse effects. Additionally, recruiting enough patients who meet the eligibility criteria can be challenging, and logistical issues such as trial site coordination and data management can complicate the process.
